The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Nektar Therapeutics competitive analysis

Loading summary...

Latest patents of Nektar Therapeutics opposed by its competitors

Explore Nektar Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3134123
Feb 17, 2021Il-2Rbeta-Selective Agonists In Combination With An Anti-Ctla-4 Antibody Or An An Anti-Pd-1 Antibody1
EP2453962
Mar 14, 2018Negatively Biased Sealed Nebulizers Systems And Methods1
EP3094331
Dec 27, 2017Combination-Based Treatment Method1

Latest PTAB cases involving Nektar Therapeutics

Discover the latest PTAB cases involving Nektar Therapeutics, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Nektar Therapeutics

IPR2019-01392Jul 25, 2019NOFNEKTAR THERAPEUTICSInstitution Denied
IPR2019-01394Jul 25, 2019NOFNEKTAR THERAPEUTICSFinal Written Decision
IPR2019-01395Jul 25, 2019NOFNEKTAR THERAPEUTICSInstitution Denied
IPR2019-01396Jul 25, 2019NOFNEKTAR THERAPEUTICSInstitution Denied
IPR2019-01397Jul 25, 2019NOFNEKTAR THERAPEUTICSFinal Written Decision
IPR2019-01398Jul 25, 2019NOFNEKTAR THERAPEUTICSFinal Written Decision
IPR2016-01384Jul 8, 2016NOVO NORDISKNEKTAR THERAPEUTICSTerminated-Settled
IPR2016-00049Oct 15, 2015NEPTUNE GENERICSNEKTAR THERAPEUTICSInstitution Denied

Peer Comparison New

IP litigation analysis comparing Nektar Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NEKTAR THERAPEUTICS - 3 - 8
GREINER6 - - -
IPSEN BIOPHARM110 - 2
NOF - - 6 -